Marly Didizian > Linklaters LLP > London, England > Lawyer Profile

The team at Linklaters LLP has broad expertise spanning trade mark infringement disputes, joint R&D agreements, and supply and logistics arrangements, often assisting financial sponsors, insurers and medical device companies. The group is also noted for its expertise in data protection, regulatory investigation, and product liability matters. Aisling Zarraga co-heads the practice, and has a great deal of expertise in handling both public and private M&A issues and joint ventures for international pharmaceutical companies, healthcare service providers and biotech corporates. Co-head Marly Didizian has broad knowledge surrounding carve outs, pharmaceutical supply chains, and advance purchase agreements involving vaccine manufacturers. Since publication, Katie Coltart has joined from Kirkland & Ellis International LLP.

Linklaters LLP leverages its substantial global footprint to advise on a broad range of multi-jurisdictional commercial issues, including negotiating collaboration agreements between BHP Billiton Group, a leading mineral resource company, and I-Pulse, as well as the cross-supply agreements for one of the largest consumer section transactions over 2022 involving Perfetti Van Melle. The firm demonstrates notable strength counselling on transformational commercial partnerships and procurements. Supply chain specialist Marly Didizian heads the team, and utilises her healthcare credentials to act on complex practice mandates such as implementing Gavi’s global COVAX Facility, alongside constructing Advance Purchase Agreements with the world’s biggest vaccine manufacturers. Richard Cumbley has been active in the retail and transport sectors, acting on a number of regulatory issues and internal restructurings, while Greg Palmer continues to advise on outsourcing and supply arrangements. Energy and technology-related issues have formed the crux of Georgina Kon‘s practice, with technical know-how regarding IT contracts, cyber and data privacy concerns. Rich Jones has a broad commercial offering. Paul Joseph joined from Norton Rose Fulbright in 2022.